FDA Inspection 1132998 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on Nov 5, 2020 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 5, 2020
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Port Jefferson Station, NY (United States)